Fiji’s health care system has challenges in its entire value chain, from inadequate infrastructure for early screening and diagnosis of disease, to availability of medical supplies and pharmaceuticals and their disposal.
This is stated in the “Country Private Sector Diagnostic – Creating Markets in Fiji” report released by the International Finance Corporation (IFC) which is a member of the World Bank Group.
“Strengthening Fiji’s health care system will help address the growing burden of non-communicable diseases (NCDs) while positioning Fiji as a regional hub for health services,” states the IFC.
“Around 85 per cent of the deaths in 2019 were due to NCDs. It is also estimated that, by 2040, the rising number of premature deaths caused by NCDs will cost Fiji’s economy roughly 10.9 per cent of the GDP.
“On the other hand, there is a lack of affordable medical insurance which acts as a key constraint to developing private health care.”
The IFC states Fiji’s health sector is also more developed in comparison with other Pacific island countries.
The IFC says greater private sector participation in advanced diagnostic facilities, telehealth services, cardiac and cancer specialist care hospital, improved storage and distribution of pharmaceuticals and strengthened medical waste management could help optimise health care service delivery domestically and position Fiji as a regional hub.
Ministry of Health permanent secretary Dr James Fong said there were definitely challenges the ministry had to address to mitigate the growing NCD burden.
“I am glad that it is being highlighted in the many discussion forums across the country,” he said.
“The adverse impact of impaired supply chains on the supply of laboratory reagents, laboratory equipment and related consumables is now more clearly visible.
“As travel borders begin to open, supply chains for international manufacturers of medicine and medical equipment are slowly recuperating, however, the impact on service provision is an acute problem.”
